Conjugating existing clinical drugs with gold nanoparticles for better treatment of heart diseases
Yes === Developing new methods to treat heart diseases is always a focus for basic research and clinical applications. Existing drugs have strong side-effects and also require lifetime administration for patients. Recent attempts of using nanoparticles (NPs) in treating atherosclerosis in animals...
| Main Authors: | , , |
|---|---|
| Language: | en |
| Published: |
2018
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10454/16530 |